Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Dissection of molecular pathways involved in controlling tumor-associated inflammation and in mediating interactions with tumor-associated macrophages (TAMs).
FY 2010-11
Summary
With the Cancer Trends Progress Report from the National Cancer Institute predicting cancer to be the leading cause of death worldwide in 2010, there is an urgent need to further dissect mechanisms involved in disease progression. Since Rudolf Virchow first report connecting inflammation to cancer in 1863, several additional evidence have emerged, including the observation that long-term use of non-steroidal anti-inflammatory drugs (NSAID), such as ibuprofen (Advil®) and salicylic acid (Aspirin®) medications that are best known for their anti-inflammatory and pain reliever properties, reduces risk to some cancers. Aspirin, for example, has been documented to reduce the risk of colorectal cancer in some cases, and potentially also influence cancers of the esophagus, stomach, breast, ovary, and lung. Of interest to this research proposal, tumor development is paralleled with the recruitment and accumulation of a specific type of immune cells called macrophages. While these cells have normally the ability to prevent the establishment and spread of tumor cells, they were reported to acquire new functions in established cancer lesions, supporting tumor growth and dissemination. Macrophages represent the greatest proportions of immune cells found in tumor sites and several studies reported associations between high levels of macrophage numbers in tumor and poor disease outcome. While tumor-derived signals and mechanisms involved in recruiting these cells and modifying their function from anti-tumor to pro-tumor have not yet been fully elucidated, several lines of evidence suggest that cross-talk between tumor and macrophage cells is an essential event. We propose to systematically dissect and analyze tumor-associated mechanisms involved in recruiting and mediating interactions with macrophages that are likely to promote inflammatory signatures observed in tumor environment. Importantly, elucidation of these mechanisms may reveal new targets for anticancer therapeutics.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
219239
Name
Villani Alexandra-Chloe
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Dissection of molecular pathways involved in controlling tumor-associated inflammation and in mediating interactions with tumor-associated macrophages (TAMs).
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Cancer; Gene Expression; Inflammation; Innate Immunity; Macrophage State Polarization By Tumor; Microarrays; Pathway Analyses; Pathways Controlling Tumor-Associated Inflammation; Shrna Gene Silencing; Tumor-Macrophage Coculture
Abstract
With the Cancer Trends Progress Report from the National Cancer Institute predicting cancer to be the leading cause of death worldwide in 2010, there is an urgent need to further dissect mechanisms involved in disease progression. Since Rudolf Virchow first report connecting inflammation to cancer in 1863, several additional evidence have emerged, including the observation that long-term use of non-steroidal anti-inflammatory drugs (NSAID), such as ibuprofen (Advil®) and salicylic acid (Aspirin®) medications that are best known for their anti-inflammatory and pain reliever properties, reduces risk to some cancers. Aspirin, for example, has been documented to reduce the risk of colorectal cancer in some cases, and potentially also influence cancers of the esophagus, stomach, breast, ovary, and lung. Of interest to this research proposal, tumor development is paralleled with the recruitment and accumulation of a specific type of immune cells called macrophages. While these cells have normally the ability to prevent the establishment and spread of tumor cells, they were reported to acquire new functions in established cancer lesions, supporting tumor growth and dissemination. Macrophages represent the greatest proportions of immune cells found in tumor sites and several studies reported associations between high levels of macrophage numbers in tumor and poor disease outcome. While tumor-derived signals and mechanisms involved in recruiting these cells and modifying their function from anti-tumor to pro-tumor have not yet been fully elucidated, several lines of evidence suggest that cross-talk between tumor and macrophage cells is an essential event. We propose to systematically dissect and analyze tumor-associated mechanisms involved in recruiting and mediating interactions with macrophages that are likely to promote inflammatory signatures observed in tumor environment. Importantly, elucidation of these mechanisms may reveal new targets for anticancer therapeutics.
Competitiondate
201011
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Villani, Alexandra-Chloe
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~